Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q8N475
UPID:
FSTL5_HUMAN
Alternative names:
Follistatin-like protein 5
Alternative UPACC:
Q8N475; E9PCP6; Q9NSW7; Q9ULF7
Background:
Follistatin-related protein 5, also known as Follistatin-like protein 5, plays a crucial role in the regulation of cellular processes. Its unique structure and alternative names highlight its significance in biological systems. The protein's specific functions remain to be fully elucidated, making it an intriguing subject for scientific inquiry.
Therapeutic significance:
Understanding the role of Follistatin-related protein 5 could open doors to potential therapeutic strategies. Its involvement in cellular regulation suggests a promising avenue for drug discovery, aiming to target diseases at their molecular roots.